Please login to the form below

Making commercial sense of switching

"WHEN YOU SWITCH a medicine from prescription to non-prescription status, everyone is required to change their behaviour" Fiona Hammond, Managing Director, Hamell

Switching hinges on changing behaviour

Changing the behaviour of key stakeholders – including consumers,healthcare professionals and regulators – lies at the heart of any successful switch of a medicine from prescription to non-pre scription status. Companies should also be prepared to rethink their ownbehaviour and expectations, writes Deborah Wilkes.

“WHEN YOU SWITCH a medicine from prescription to non-prescription status, everyone is required to change their behaviour,” says Fiona Hammond, managing director of Hamell Communications.

Read more:

14th September 2015


Company Details


020 7978 5206

Contact Website

1st Floor
Dome Building
The Quadrant

Latest content on this profile

Making good practice common practice in rare disease

Hamell celebrate creativity! Orrin Pollard selected as juror at the 2017 Cannes Lions Festival of Creativity

Hamell’s new Head of Patient and Consumer Engagement invigorates their consumer and patient communication capabilities
Linda Cowie brings in new business as Head of Patient and Consumer Engagement
We want to become more active, so why are we still failing?
Hamell share the results of a recent behavioural study using wearables
Don't make me laugh!
Orrin Pollard, our Executive Creative Director, reflects on the power of humour to inspire behaviour change
Health inequality: One of the most commonly overlooked factors in behaviour change
The most effective behaviour change interventions identify and resonate with their entire target audience. They consider and accommodate health inequality.